Business

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases

Financial Post · September 15, 2026 at 6:01 a.m.

TORONTO -- QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS).

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases

More from Financial Post

Duncan Solutions Completes Transition to Standalone Tech- and AI-Enabled, End-to-End Transportation Revenue Cycle Management Platform

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity

Posthaste: Data centre anger is boiling over in Canada and here’s where opposition is highest

More in Business

Duncan Solutions Completes Transition to Standalone Tech- and AI-Enabled, End-to-End Transportation Revenue Cycle Management Platform

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity

Posthaste: Data centre anger is boiling over in Canada and here’s where opposition is highest

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care